Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry (vol 116, pg 413, 2014)

Por: Gallego, O, Cuatrecasas, M, Benavides, M, Segura, PP, Berrocal, A, Erill, N, Colomer, A, Quintana, MJ, Balana, C, Gil, M, Gallardo, A, Murata, P, Barnadas, A

---

Publicada: 1 dic 2014

---

---

Filiaciones:
Gallego, O:
 Santa Creu & St Pau Hosp, Med Oncol Serv, Barcelona 08025, Spain

Cuatrecasas, M:
 Hosp Clin Barcelona, Dept Pathol, Barcelona, Spain

Benavides, M:
 Carlos Haya Hosp, Med Oncol Serv, Malaga, Spain

Segura, PP:
 San Carlos Univ Hosp, Med Oncol Serv, Madrid, Spain

Berrocal, A:
 Valencia Gen Univ Hosp Consortium, Med Oncol Serv, Valencia, Spain

Erill, N:
 Althia Hlth, Barcelona, Spain

Colomer, A:
 Althia Hlth, Barcelona, Spain

Quintana, MJ:
 Santa Creu & St Pau Hosp, Med Oncol Serv, Barcelona 08025, Spain

Balana, C:
 Hosp Badalona Germans Trias & Pujol, Catalonian Inst Oncol, Med Oncol Serv, Barcelona, Spain

Gil, M:
 Catalonian Inst Oncol, Med Oncol Serv, GEINO, Barcelona, Spain

Gallardo, A:
 Clin Girona, Dept Pathol, Girona, Spain

Murata, P:
 Santa Creu & St Pau Hosp, Med Oncol Serv, Barcelona 08025, Spain

Barnadas, A:
 Univ Autonoma Barcelona, E-08193 Barcelona, Spain